focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Ormonde Mining acquires stake in Peak Nickel

Tue, 07th Feb 2023 19:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Haydale Graphene Industries PLC - Ammanford, Wales-based graphene technology company - Says that its "bespoke" mechanical graphene is used to create kayaks for Norse Kayaks. Adds that the Norse kayak is 30% lighter to 16 kilogrammes from 23kg. "The use of graphene has exceeded our expectations and we are sure that this will set a new standard of what is possible to do with a sea kayak. We have never seen this kind of impact strength on light weight sea kayaks in our 20 years' experience in the kayaking business," Norse founder Kjetil Sandvik says.

----------

Tekcapital PLC - London-based intellectual property investor - Launches its Lucyd Lyte 2.0 eyewear. Intends to introduce the product to optical and speciality retail chains worldwide. Notes that it is a "major upgrade" to its flagship Lucyd Lyte audio eyewear platform.

----------

Witan Investment Trust PLC - investment firm - Declares a fourth interim dividend of 1.60p per ordinary share, taking it total dividends for 2022 to 5.80p. Intend to grow its dividend "in real terms," ahead of inflation. Notes that its dividends have grown "substantially" ahead of UK inflation over the past 5 and 10 years.

----------

Ormonde Mining PLC - cash shell, former Dublin-based mineral resource company - Is temporarily suspended from trading on AIM on Wednesday, "pending an announcement and publication of an admission document." Explains that it became a cash shell in October 2022 and was therefore required to announce an acquisition or acquisitions that would be a reverse takeover. Says that it acquired a 20% stake in Peak Nickel Ltd for GBP450,000. Adds that it was granted an option to invest a further GBP4 million in cash in PNL, taking its stake to 49.9% and to buy the remaining 80% of PLN through the issue of Ormonde ordinary shares. Notes that this option can be exercised following the completion of the initial work programme. Notes that the exercise will be dependent on the results of the work programme, among other things, but satisfy the AIM Rule 14 conditions in relation to being a cash shell.

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Files four new patent applications to protect "innovations" around novel gene targets, associated disease-relevant biology and proprietary siRNA stabilisation chemistries. siRNA is short for small interfering RNA. Notes that the new applications build on a period of IP generation in 2022, where a series of patent applications were filed to protect 13 inventions. "This latest announcement of patent filings reflects our continued pace of innovation and progress towards an in-house pipeline of first-in-class RNAi candidates derived from our computational platform. We will continue to build on this progress, maintain the momentum of invention and actively protect our expanding intellectual property portfolio," CEO Ali Mortazavi comments.

----------

Lok'n Store Group PLC - Hampshire, England-based self-storage - Says that its board approved a transition for its shares on AIM to the Stock Exchange Electronic Trading System platform from the London Stock Exchange's Stock Exchange Electronic Trading Service. The move was effective from February 7. Explains that the move is supposed to provide investors with access to the entire SETS system, "providing liquidity via traditional order book trades, as well as firm two-way quotes from market makers."

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 May 2014 10:51

e-Therapeutics Trading Up As Brain Cancer Trial To Resume Recruitment

LONDON (Alliance News) - Shares in e-Therapeutics PLC were trading higher Thursday after it said that it had been cleared by the US Food and Drug administration to resume recruiting patients for its Phase Ia study of compound ETS2101 in brain cancer. The company had previously paused recrui

Read more
7 Apr 2014 12:25

UPDATE: e-Therapeutics Appoints Steve Medlicott Chief Financial Officer

LONDON (Alliance News) - e-Therapeutics PLC Monday said that it had appointed Steve Medlicott as Chief Financial Officer, following the resignation of Daniel Elger with immediate effect, also announced Monday. Medlicott had advised the company on its GBP40 million fund-raising in 2013. Medl

Read more
7 Apr 2014 10:57

e-Therapeutics's Chief Financial Officer Daniel Elger Resigns

LONDON (Alliance News) - e-Therapeutics PLC Monday said that Daniel Elger has resigned as Chief Financial officer and a director of the company, with immediate effect. e-Therapeutics said that the company's finances will be managed on an interim basis by Paul Stockdale, who has been the com

Read more
31 Mar 2014 12:50

REPEAT: UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Fluo

Read more
31 Mar 2014 12:45

UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Flou

Read more
31 Mar 2014 10:35

UK WINNERS & LOSERS: Babcock Leads FTSE 100 Risers; Insurers Rebound

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Babcock International Group, up 3.5%. The company said its Cavendish Fluor Partnership has

Read more
31 Mar 2014 08:33

e-Therapeutics Rises As It Gets Good Interim Drug Trial Results

LONDON (Alliance News) - e-Therapeutics PLC Monday said it had achieved positive interim results from a UK study evaluating the safety, dosing and anti-tumour activity of its ETS2101 drug in patients with advanced solid cancer tumours. In a statement, the company said that it had completed

Read more
26 Mar 2014 13:40

UK MIDDAY BRIEFING: Government Completes 2nd Lloyds Bank Stake Sale

LONDON (Alliance News) - The UK government has raised a further GBP4.20 billion from its second sale of Lloyds Banking Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million that taxpayers injected into the bank during the financial crisis.<

Read more
26 Mar 2014 11:30

UK WINNERS & LOSERS: Standard Life Leads FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Standard Life, up 5.2%. The company has agreed to buy Ignis Asset Mana

Read more
26 Mar 2014 11:03

e-Therapeutics Gains As Recruitment For Cancer Trial Resumes

LONDON (Alliance News) - Shares in e-Therapeutics PLC jumped Wednesday morning after the biotechnology company said it has received approval from MHRA to recommence recruitment of new patients into its ETS2101 phase Ia solid tumours trial. Recruitment for the trial was temporarily paused ov

Read more
24 Jan 2014 12:41

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.

In a speech at the World Ec

Read more
24 Jan 2014 11:01

e-Therapeutics Temporarily Halts Recruitment In Trial Due To Drug Supply Issue

LONDON (Alliance News) - Shares in e-Therapeutics PLC dropped 16% Friday morning after it said that it was temporarily halting recruitment into its ETS2101 cancer trials due to a drug supply issue. e-Therapeutics said that there had been a practical issue with the stored drugs for the trial

Read more
24 Jan 2014 10:58

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide

Read more
7 Jan 2014 08:22

AIM IN BRIEF: H&T Says Profit As Expected, But Gold Price Has Hurt

Read more
31 Oct 2013 13:36

e-Therapeutics Starts Phase IIb Trial Of Depressive Disorder Treatment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.